Any number crunchers have any idea what Shire would fetch if this happens. I'm told Shire is would make great aquisition by larger pharmaceutical co. My CPA friend says easily $100+ Any ideas out there? Regards,Sonar
Press Release from Bloomberg News and AOL News this afternoon (Aug.1) stated J&J got an "Approvable Letter" from FDA for Reminyl. Get ready to say goodbye to Aricept.
In other SHPGY-related news today, Alza announced approval of Once-daily Concerta for ADHD. The good side to this news for SHPGY is that it's still just methylphenidate, therefore more likely to be carnivorous to shorter acting versions of the same agent (Ritalin/methylphenidate). When methylphenidate does work that's great, when it doesn't there's Adderall.
Thank you for the information. Is is true that they are reporting Q2 numbers tomorrow? What are those expected to be. I bought this stock based on a broker rec. and it's done nothing positive. I only like going down in roller-coasters. Haave a good one.
No, they have European approval, but not FDA approval yet. The NDA dossier was submited in Sept 99. Usually the FDA requires about a year to respond, so we are expecting to hear something soon. While FDA doesnt always approve the same drugs that are approved in Europe, we can hope that the European approval increases the likelihood that it will be approved here. When the drug was first approved in Sweden, the price shot up almost 10 points. Then when it was approved in the rest of Europe, the rally began again. So we can hope that if it is approved by the FDA there will be another positive impact on price. Does anybody have anything to add to this?
I understand your position. I held it as well. But this stock has been very high for quite a while. I still think Rolf should fire those VPs in Kentucky. I don�t think they run their business like a true pharma company, and I still don�t like a lot of their management decisions, but I cannot deny the stock price. You may be correct in assuming that Shire may have trouble meeting Q3+ numbers. IMNSHO, Shire won�t EARN it�s stock price, it will AQUIRE it. I don�t have faith in Shire�s management below Rolf. From Rolf above, I think they are quite shrewd. They will acquire another company soon. The big question regarding a decrease in stock price will be �How will the acquisition effect the stock short term?�. I think we may see some buying opportunities during the arbitrage period. I only wish I knew who they are buying. Anybody got any ideas?
Thanks. Shire definitely seems to have more friends than Roberts ever did. As an old RPC long, I wished for this kind of support from institutions for Roberts, but we never got it. Shire�s big investors appear to be smart enough to see the big picture.